Website search
Results for "covid"
Impact report launches: UCLB spinouts attracted £3bn investment in last five years
UCLB spinouts, formed to commercialise and scale up innovations in research, have created more than 2,200 new jobs and attracted almost £3bn in investment in the last five years, according to a new report from UCLB, UCL’s technology transfer company.
Professor Elizabeth Murray’s legacy continues as Healthy Living reaches 20,000 milestone
Healthy Living, an initiative based on the late UCL Professor Elizabeth Murray’s HeLP Diabetes programme, has reached a milestone 20,000 users, NHS England (NHSE) has announced.
Episode 8: Senceive Ltd: An organic growth success story - TRANSCRIPT
Episode 7: Project Management for Technology Transfer
Episode 6: A journey from Senior Business Manager to Corporate Development at Autolus - Transcript
Episode 5: Evolving AI solutions in business - Transcript
Episode 3: Beating Cancer - Transcript
Episode 4 : e-lucid: developing an innovative express licensing platform - Transcript
The antibody sequencing system driving targeted drug design
The global demand for targeted, effective treatments for a wide range of diseases has led to significant growth in the number of antibody drugs. A third of all new medicines under development involve an antibody therapy. They account for more than 100 licensed treatments for cancer, autoimmune disease and blood clotting, and over 200 were in development during the COVID-19 pandemic to tackle the virus.